The results of two completed clinical trials of the curaxin CBL0137 (oral and intravenous administration) in patients with advanced solid tumors will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2020 during the Poster Session: Developmental Therapeutics – Molecularly Targeted Agents and Tumor Biology (posters #337 and #313). Join us on […]
The results of the research which describe the curaxin CBL0137 mechanism of action will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2020 by Professor Katerina Gurova from the Roswell Park Comprehensive Cancer Center. These studies were supported by Incuron. Join us on April 24-29, 2020, in San Diego, California.
Incuron will be presenting as a Top Innovator at the Life Sciences Track of The 2019 New England Venture Summit. Join us in Boston on December 4, 2019.